Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
This Month’s Highlights
You have accessRestricted Access

This Month's Highlights

JASN February 2021, 32 (2) i; DOI: https://doi.org/10.1681/ASN.2020121749
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

NAD, Lipid Metabolism, and Acidosis-Induced AKI

Clinical studies have suggested that metabolic acidosis aggravates tubular damage in patients with either AKI and CKD, but the mechanisms have been unknown. Using intravital live cell imaging and other complementary techniques, the authors demonstrated in the mouse kidney that metabolic acidosis induces acute changes in the mitochondrial NAD redox state, respiratory chain function, and lipid metabolism, which collectively lead to tubular cell damage. Intravenous injection of bicarbonate increases blood pH and improves tubular function, whereas pretreatment with an NAD precursor is highly protective. Thus, changes in cell metabolism explain the harmful effects of metabolic acidosis on kidney tubules. There are viable strategies to ameliorate these effects in patients. See Bugarski et al., pages 342–356.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Model of Pregnancy-Associated AKI

Increasing evidence suggests that patients have lingering subclinical damage after AKI, despite clinical recovery as defined by serum creatinine levels. Recent findings indicate that women with a history of AKI have poorer maternal and fetal outcomes in pregnancy, suggesting that subclinical injury impairs the renal response. The authors demonstrated that after female Sprague Dawley rats experienced biochemical resolution of surgically induced renal ischemia-reperfusion injury, they subsequently developed renal insufficiency during pregnancy and intrauterine growth restriction. This novel model may serve as a useful preclinical tool to address the critical gap in knowledge regarding the mechanisms by which AKI predisposes to adverse pregnancy outcomes. See Gillis et al., pages 375–384.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Kidney Histology and Graft Rejection Prediction

Many kidneys donated for transplantation are discarded because of abnormal histology discovered in a preimplantation biopsy. In an analysis of data from transplant centers in France and Belgium, where pretransplant biopsies are prospectively performed as standard practice but do not guide organ allocation decision-making, Reese et al. found that transplant histology did not improve the prediction of allograft failure beyond a baseline set of donor and recipient characteristics. They also found that kidneys transplanted in Europe that were similar to discarded donor kidneys from deceased US donors had acceptable allograft survival, suggesting lost transplant opportunities in the United States. See Reese et al., pages 397–409.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Air Pollution and CKD Risk

Minimal data exist on how exposure to high levels of an air pollutant, fine particulate matter (PM2.5), such as in areas of mainland China, may affect CKD risk. In their analysis of data from a large survey of Chinese adults, Li et al. demonstrated significant associations between long-term exposure to high ambient PM2.5 levels and an increased risk of CKD prevalence and albuminuria. These associations were significantly stronger in urban areas, among males, and among individuals <65 years and those with comorbidities. These findings offer insight for target population protection and offer evidence that policies to reduce ambient PM2.5 pollution may lower CKD risk. See Li et al., pages 448–458. Also see related editorial by Al-Aly and Bowe, pages 260–262.

CKD Darbepoeitin Dosing Strategy and Transfusions

Historically, erythropoietin-stimulating agents have been titrated to achieve a predefined hemoglobin concentration when treating CKD patients with anemia. This randomized trial was designed to describe the benefits and potential risks of a new treatment strategy, using a low fixed dose of darbepoetin alfa compared with a hemoglobin-based titration-dose algorithm. The authors show that use of a low fixed dose of darbepoetin may be an alternative to a dose-titration approach to minimize red blood cell transfusions in CKD patients with anemia, and results in a smaller cumulative dose. See Toto et al., pages 469–478.

Antibody-Mediated Rejection

In kidney transplant recipients whose donor-specific antibodies (DSAs) do not activate complement, recruitment of innate immune effectors, particularly natural killer (NK) cells, mediates graft destruction. Combining observations from a cohort of kidney transplant recipients with antibody-mediated rejection (AMR), transcriptomic data, and use of in vitro models, Koenig et al. demonstrated that the capacity of the recipient’s NK cells to sense absence of self HLA-I molecules (i.e., missing self) on graft vasculature synergizes with DSA-dependent NK cell activation to worsen the outcome of complement-independent chronic AMR. Thus, screening for missing self could help to stratify risk of graft failure and guide a personalized therapeutic approach in patients with AMR. See Koenig et al., pages 479–494. Also see related editorial by Hidalgo, pages 262–264.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
  • Copyright © 2021 by the American Society of Nephrology
PreviousNext
Back to top

Podcast

Subscribe to podcast
Download MP3

In this issue

Journal of the American Society of Nephrology: 32 (2)
Journal of the American Society of Nephrology
Vol. 32, Issue 2
February 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
This Month's Highlights
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
This Month's Highlights
JASN Feb 2021, 32 (2) i; DOI: 10.1681/ASN.2020121749

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
This Month's Highlights
JASN Feb 2021, 32 (2) i; DOI: 10.1681/ASN.2020121749
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • This Month's Highlights
  • This Month's Highlights
  • This Month's Highlights
Show more This Month’s Highlights

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire